|
CA2571569A1
|
|
Use of targeted oxidative therapeutic formulation in endodontic treatment
|
|
EP1768661A1
|
|
Use of targeted oxidative therapeutic formulation in treatment of burns
|
|
CA2566180A1
|
|
Use of targeted oxidative therapeutic formulation in treatment of cancer
|
|
CA2566190A1
|
|
Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
|
|
EP1750768A2
|
|
Use of targeted oxidative therapeutic formulation in bone regeneration
|
|
CN101027087A
|
|
Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity
|
|
WO2005082342A1
|
|
Use of targeted oxidative therapeutic formulation in treatment of viral diseases
|
|
AU2002258600A1
|
|
Uses of targeted oxidative therapeutic formulation in arteriosclerosis
|
|
EP1385525A2
|
|
Targeted oxidative therapeutic formulation
|
